(Q84496846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

S Abhyankar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S DeJarnette

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

O Aljitawi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

S Ganguly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

D Merkel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

J McGuirk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

4 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

483-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21725372%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2011.133

6 February 2020

exact match

0 references

cites work

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

AMD3100 is a CXCR7 ligand with allosteric agonist properties

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021

Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.133

7 January 2021